本报讯（记者 胡家林 李莎）12月26日，记者从省政府新闻办召开的新闻发布会上获悉，贵州近年来实 施全民参保计划，已建成"一人一档"全民参保数据库，截至2025年11月底，全省基本医保参保人数达 4104.76万人，其中职工医保524.55万人，居民医保3580.21万人。今年以来，全省共有1.16亿人次享受居 民医保报销329.41亿元。 为提升医保基金抗风险能力和统筹层次，我省自2024年12月起推进基本医保省级统筹。通过风险调剂模 式，从城乡居民医保起步，逐步覆盖职工医保，分步稳妥推进基本医保省级统筹。 转自：贵州日报 医保服务便捷性同步增强。全省打造"多渠道、一网通"经办体系，医保移动支付、诊间结算广泛普及。 目前，3960万人激活医保码，10925家医药机构开通"刷脸支付"，241家二级及以上医疗机构实现"移动 支付"，群众就医实现"一码通办"。建成覆盖省、市、县、乡、村的五级医保服务网络，28项业务"全省 通办"、7项"跨省通办"、16个重点事项可一次"高效办成"。异地就医更便捷，省内住院全面取消备案， 跨省备案手续简化，住院费用直接结算率达87.62%。 2026年度居民医保征缴工作已启动，个人 ...

Core Viewpoint - UnitedHealth Group (UNH) faces significant challenges due to political pressure for lower health insurance premiums, which could impact its profitability and stock performance in 2026 [4][12][15]. Company Overview - UnitedHealth Group, founded in 1974, operates in health insurance and healthcare services, organized into two main divisions: UnitedHealthcare and Optum, with a market cap of $294.2 billion [3]. Stock Performance - UNH stock has rebounded to $381 since early August, supported by Berkshire Hathaway's investment and positive 2026 Star Ratings, but has since entered a consolidation phase [1]. - Year-to-date, UNH shares have dropped 35.2%, primarily due to a cut and subsequent withdrawal of full-year earnings guidance, a DOJ investigation into billing practices, and the CEO's resignation [2]. Political and Regulatory Environment - President Trump's recent remarks about calling health insurance executives to lower premiums have created uncertainty in the sector, as pricing power may come under political scrutiny [5][6][8]. - The push for lower premiums is linked to the expiration of enhanced Affordable Care Act (ACA) subsidies at the end of 2025, which could lead to a significant increase in out-of-pocket premiums for many Americans [10]. Market Reactions - Following Trump's comments, UNH shares fell nearly 10% before slightly recovering, reflecting investor concerns about the potential impact on earnings due to pricing pressures [8][12]. - Analysts remain generally bullish on UNH, with a consensus "Moderate Buy" rating and a mean price target of $394.91, indicating a potential upside of 20.5% from current levels [16]. Financial Implications - Lowering premiums without a corresponding decrease in medical costs could compress margins and negatively affect profitability, leading to sustained declines in valuation as investors adjust expectations for future earnings [13][15]. - The American Health Insurance Plans (AHIP) trade group emphasizes that premiums are driven by medical care costs and that insurers are working to shield consumers from rising expenses [14].

Company Overview - UnitedHealth Group Incorporated (UNH) has a market cap of $294.2 billion and operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx, providing health benefits, care delivery, data-driven health services, and pharmacy care solutions [1] Financial Performance - For fiscal Q4 2025, analysts predict an adjusted EPS of $2.09, a significant decline of 69.3% from $6.81 in the same quarter last year [2] - For fiscal 2025, the expected adjusted EPS is $16.30, down 41.1% from $27.66 in fiscal 2024, but anticipated to grow nearly 8% year-over-year to $17.60 in fiscal 2026 [3] Stock Performance - UNH stock has decreased by 35.9% over the past 52 weeks, underperforming the S&P 500 Index's gain of 15.7% and the State Street Health Care Select Sector SPDR ETF's rise of 11.7% during the same period [4] Recent Developments - Despite weaker-than-expected Q3 2025 revenue of $113.16 billion, UNH shares rose slightly as the company reported an adjusted EPS of $2.92, exceeding analyst estimates. The company also raised its 2025 adjusted profit forecast to at least $16.25 per share, indicating confidence in future growth starting in 2026 and progress in stabilizing costs with a medical care ratio (MCR) of 89.9% [5] Analyst Ratings - The consensus rating for UNH stock is "Moderate Buy," with 15 "Strong Buys," 2 "Moderate Buys," 7 "Holds," and 1 "Strong Sell" among 25 analysts. The average price target is $394.91, suggesting a potential upside of 21.6% from current levels [6]

Core Viewpoint - eHealth, Inc. (EHTH) has raised its financial outlook for fiscal year 2025 following stable performance during the Annual Enrollment Period (AEP), particularly in its Medicare business [1][8]. Financial Outlook - The company now forecasts total revenue of approximately $540-$560 million, an increase from previous guidance, and GAAP net income between $30-$45 million, which is significantly higher than earlier projections [1][8]. - Adjusted EBITDA is expected to range from $80-$95 million, up from the prior range of $60-$80 million [2][8]. - The Zacks Consensus Estimate for 2025 bottom line is currently at 29 cents per share, indicating a 119% year-over-year improvement, with expectations for further growth to $1.88 per share in 2026 [2]. Factors Driving Performance - The updated outlook is attributed to stable enrollment results during AEP, a shift towards higher-quality direct branded channels, and the implementation of AI tools that have enhanced marketing efficiency and sales conversion [5][6]. - The lifetime value in the fourth quarter is expected to grow year-over-year due to higher commission rates and improved persistency trends [5]. Market Position and Strategy - eHealth is demonstrating improved profitability and operational discipline, which strengthens confidence in its execution after previous financial pressures [6]. - The company is effectively navigating a competitive Medicare market by leveraging technology and channel strategies to drive results, indicating that its key enrollment period can significantly impact full-year prospects [6][8]. Stock Performance - eHealth shares have increased by 7.3% over the past three months, outperforming the broader industry and the S&P 500 Index [9]. - The company trades at a forward price-to-sales ratio of 0.25X, significantly lower than the industry average of 3.22X, although it carries a Value Score of C [12].

Group 1 - Elevance Health will release its fourth quarter and full year 2025 financial results on January 28, 2026, at 6:00 a.m. EST [1] - A conference call to review these results and the company's outlook will take place at 8:30 a.m. EST on the same day [1] - The conference call can be accessed via specific domestic and international numbers, with a replay available from January 28, 2026, until February 27, 2026 [3] Group 2 - Elevance Health serves 109 million consumers through a diverse portfolio of healthcare solutions, including medical, pharmacy, behavioral, clinical, home health, and complex care [2] - The company's purpose is to improve the health of humanity by supporting consumers, families, and communities throughout their healthcare journey [2]

LAS VEGAS--(BUSINESS WIRE)--The MolinaCares Accord and Molina Healthcare of Nevada Donate $187,000 to Support Local Food Banks Facing Increased Demand. ...

As president, I'm also taking on the gigantic health insurance companies that have gotten rich on billions of dollars of government subsidies. And I want the money to go directly to the people. I want the money to be paid directly to the people so that they can buy their own health insurance which will give far better benefits at much lower cost.By the way, what I told you about buying the drugs at this massive uh dollar discount, it's like from where it is, that's going to have a huge impact on the cost of ...

Digital assets companies achieved a breakthrough with the passage of a light-touch regulatory law for dollar-pegged stablecoins, clearing the way for broader use of the technology in everyday finance. An industry drive for a broader rewrite of securities and commodities laws to set up favorable regulation of cryptoassets is moving closer to the finish line. A $263 million campaign war chest the crypto industry has amassed in super-PACs is sure to help.Energy companies secured a tax break worth more than $1 ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. UnitedHealth has pledged to make a range of improvements in response to the first outside reviews of its business practices as the healthcare behemoth works to improve waning consumer trust. The independent analyses, completed by FTI Consulting and the Analysis Group in November and released on Friday, didn’t find a smoking gun that UnitedHealth is leveraging ...

Group 1 - UnitedHealth Group Incorporated (NYSE:UNH) is undergoing operational changes due to audits of its health services and pharmacy benefit units, focusing on increased automation and standardization [1] - CEO Stephen Hemsley announced a comprehensive examination of managed care practices and pharmacy benefits, with 23 action plans already in progress, over half of which will be finalized by the end of this year [2][3] - UnitedHealth Group will share the results of the HouseCalls visit review in fiscal Q1 2026 [3] Group 2 - UnitedHealth Group reported that Optum Rx is modernizing pharmacy reimbursement methods, partnering with three additional Pharmacy Services Administration Organizations (PSAOs) to implement cost-based contracts for over 17,000 community pharmacies [4] - The initiative aims to better support community pharmacies, with 100% of community and independent pharmacies in the Optum Rx network transitioning to the new reimbursement model [5] - UnitedHealth Group operates through various segments, including OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare, providing healthcare coverage, data consultancy, and software services [5]